Pure Global

Qualitative/Quantitative Assay for IgM Antibodies Against Cytomegalo Virus - Vietnam Registration 2402537ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative/Quantitative Assay for IgM Antibodies Against Cytomegalo Virus in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402537ĐKLH/BYT-HTTB and manufactured by Institut Virion\Serion GmbH. The authorized representative in Vietnam is CÔNG TY TNHH THƯƠNG MẠI Y TẾ PHÚ GIA.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402537ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402537ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative/Quantitative Assay for IgM Antibodies Against Cytomegalo Virus
VN: Bộ xét nghiệm định tính/định lượng kháng thể IgM kháng vi rút Cytomegalo
Risk Class TTBYT Loại C

Registration Details

2402537ĐKLH/BYT-HTTB

000.00.04.G18-220504-0106

SERION ELISA classic Cytomegalovirus IgM

ESR109M

Company Information

GERMANY

Institut Virion\Serion GmbH

Technical Details

The SERION ELISA classic Cytomegalovirus IgM test is a qualitative and quantitative immunoassay to detect antibodies in the blood or serum of humans against Cytomegalovirus. The SERION ELISA classic Cytomegalovirus IgM test is recommended for the detection of acute infections. IgM antibodies against Cytomegalovirus are often detected in cases of polyclonal activation and can persist for a long time. The SERION ELISA classic Cytomegalovirus IgM test is suitable for newborn screening with dried blood spots (DBS)

Dates and Status

Aug 30, 2024